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Abstract: Recent few studies revealed that
increased levels of oxygen free radicals might
play a role in tissue damage. There are some
studies in the literature proposing that
increased levels of oxygen radicals might play
a role in tissue damage, as also seen in
Behçet’s disease (BD). The aim of the present
study was to measure plasma malondialdehyde (MDA) (as an index of lipid peroxidation) levels in 23 patients with BD (13 men,
10 women with a mean age of 34.5 ± 7.2
years) both in active and in remission periods.
Twenty-one healthy volunteers (11 men, 10
women) formed as the control group.

It was found that mean plasma MDA levels
were significantly higher both in the active
(11.147 ± 2.452 nmol/mL) and remission
(8.056 ± 1.916 nmol/mL) periods in patients
with BD than in the controls (4.978 ± 1.431
nmol/mL) (p<0.001 for both).
It was concluded that the plasma antioxidant
defence system was significantly more
impaired in active phase than in remission
phase of BD.
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Introduction

Materials and Methods

Behçet’s disease (BD) is named eponymously for the
Turkish dermatologist who described a symptom complex
of oral and genital ulceration and iritis (1). Recent studies
have shown that the disease is a multisystem disorder
that affects skin, mucous membranes, eyes, joints,
central nervous system and blood vessels (2, 3). Vasculitis
is also defined as a major feature of the disease (4). The
exact cause of BD is still unknown, but the list of possible
agents in the pathogenesis of this disorder is long and
includes genetic factors, viral infections, allergies to
bacteria and several immunologic abnormalities (5). In
addition to such factors, increased levels of oxygen free
radicals may play a role in tissue damage in BD (6-8).
Oxygen free radicals can lead to lipid peroxidation
reactions as a result of which malondialdehyde (MDA) is
produced (8, 9).

Twenty-three patients with BD admitted to the
Department of Dermatology at Atatürk University were
included in this study. The diagnosis was made according
to international criteria for classification of BD (1).
Patients were examined in both active and remission
periods, and their blood samples were taken for the
measurement of plasma MDA levels. At both periods;
patients were subjected to a complete history and physical
examination, complete blood counts, total and differential
white blood cell counts, erythrocyte sedimentation rate,
C-reactive protein, liver function tests, creatinine and
urinalysis. Venous blood was collected in heparinized
tubes and centrifuged at 2000xg for 10 minutes. Plasma
aliquots were stored at -70˚C until assayed. Each sample
was studied in duplicate. MDA was estimated according to
the method of Satoh (11). Briefly, 2.5 mL of 20%
trichloroacetic acid and 1 mL of 0.67% thiobarbituric
acid were added to 0.5 mL of serum. The mixture was
then heated in boiling water for 30 min. The resulting
chromogen was extracted with 4 mL of n-butyl alcohol
and the absorbance of the organic phase was determined
at 530 nm. Malondialdehyde-bis-diethyl-acetal was used
as a standard and the values were presented as nmol/mL.

There are very few reports in the literature regarding
antioxidants and lipid peroxidation in BD (6), and up to
now, only one study has been done related to plasma
MDA measurement in both at active and remission
periods of this disease (10). This was the aim of the
present study.
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Twenty-one healthy subjects matched with the patients
for age and sex formed the control group. The results
were given as mean ± SD values. The significance of the
mean differences between groups was assessed by the
Mann Whitney-U test. A value of p<0.05 was considered
significantly different.

Table 2.

MDA in plasma of patients with BD active and remission
periods, and of controls.

Cases

(mean ± SD)

Controls (n: 21)

Results
This study included 13 male and 10 female patients
with ages ranging from 18 to 56 years (mean: 34.5 ±
7.2 years) and a control group (11 men and 10 women)
with ages ranging from 20 to 60 years ( mean: 36.2 ±
6.8 years). The duration of BD ranged from 2 to 15 years
with a mean age of 8.4 ± 2.3 years. Oral and genital
ulcerations were present exclusively in all patients with
lesions at various sites of various degrees of severity.
Fifteen patients had ocular findings that were interpreted
as BD. Six patients had papulopustular eruption on the
trunk. Five patients had mild to moderate arthralgia and
arthritis. Two patients had gastrointestinal complications.
One patient suffered from headaches (Table 1).
Table 1.

Clinical findings of patients.
Finding

n

Oral and genital ulceration

23

Ocular findings

15

Papulopustular eruption

6

Arthritis and arthralgia

5

Gastrointestinal complaints

2

Headeche

1

In all of the patients with active and remissive BD,
mean plasma MDA was found to be above the normal
range. When compared to controls, plasma levels of MDA
were significantly higher in both active and remission
periods in BD patients (p<0.001, for both). Additionally,
there was a significant difference between the MDA
values ofpatients in active and remission phases
(p<0.001). The data of the present study are presented
in table 2.
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MDA levels (nmol/ mL)

4.978 ± 1.431*

Patients at active period of BD (n: 23)

11. 147 ± 2.452*

Patients at remission period of BD (n: 23)

8.056 ± 1.916*

* p< 0.001; controls vs patients in both active and inactive period, and patients in
active vs remission period.

Discussion
There is growing evidence that oxygen-derived free
radicals a play a role in the pathogenesis of various
inflammatory diseases. Leukocyte infiltration is a common
feature of inflammatory disorders, and the resultant
oxygen-derived free radicals may account for the
alternation in vascular and mucosal permeability. With
increasing frequency, inflammatory cells, particularly
polymorphonuclear cell (PMN) leukocytes, are being
implicated as mediators of tissue-destructive events in
inflammatory diseases. Inflammatory cells attracted to
the site of injury are capable of greatly increasing
reactive oxygen species during respiratory burst.
Antioxidant mechanisms exist for the control of the
effects of reactive oxygen species (ROS). However, there
is evidence to suggest that the continual production of
free radicals within the inflammed region may result in
the exhaustion of effective antioxidant control (6,12-14).
In other words, the antioxidant mechanism fails, and then
the severity of destruction increases, because ROS can
react with vital biological substances, such as proteins,
nucleic acids and polyunsaturated fatty acids. The reaction
of ROS with polyunsaturated fatty acids leads to the
formation of MDA, which is a marker of lipid peroxidation
(15,16).
BD is a chronic inflammatory disease of unknown
aetiology. The stimulated neutrophils seen in BD have
been considered to be correlated with the pathogenesis of
BD. In particular, oxidative species such as O2- , which are
reported to be increased in BD, have been proposed as
possible mediators for tissue damage occurring in BD (7,
8, 17). In a study by Pronai et al. (18), it was determined
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that the superoxide scavenging activity (SSA) of PMN
were lower in BD patients, and there were negative
correlations between the SSA of PMN. Their O2generation by PMN in vivo might be responsible for the
decreased SSA of PMN in BD, and PMN might be able to
release more O2- in tissue. Consequently, increased
generation of O2- may lead to more lipid peroxidation in
the tissues of patients with BD.
As yet, although there have been some studies on
antioxidative enzymes and lipid peroxidation in BD (6, 7),
there is only one study on MDA measured both during
active and remission periods of BD (10). Freitas et al.
reported that thiobarbituric acid reactive substances
(expressed as nanomoles MDA per milliliter) were
significantly higher in BD patients than in healthy
controls; however, they did not group BD patients at
active or at remission periods (19). Orem et al. studied

lipid peroxidation in 18 BD patients and detected that
lipid peroxidation was higher in the active period than in
the inactive period of the disease and in control subjects
(10).
The main finding of the study was that plasma MDA
level was higher in both active and remission periods of
BD than in healthy controls, and additionally, that patients
in the active period had much higher plasma MDA levels
than the values obtained in the remission period. Our
results confirm the previous studies (10, 19). These data
indicate that lipid peroxidation becomes more prominent
in active phase of BD. However, it is uncertain whether
increased lipid peroxitation, or in other words, the
impaired antioxidant defence system, is a cause or a
consequence of this disease. Detailed studies are needed
to clarify the situation.
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